Market Cap
AstraZeneca plc
£186.90 Billion
GBP as of July 1, 2024
US$236.45 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
AbbVie | $295.34 B |
Novartis | $219.78 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
AstraZeneca PLC is an Anglo–Swedish multinational pharmaceutical and biopharmaceutical company. AstraZeneca develops, manufactures, and sells pharmaceuticals and biotechnology products to treat major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
AstraZeneca plc has the following listings and related stock indices.
Stock: LSE: AZN
Stock: BCBA: AZN
Stock: BMV: AZNN
Stock: FSX: ZEG
Stock: FSX: ZEGA
Stock: OMX: AZN
Stock: OTC: AZNCF
Stock: NASDAQ: AZN
Stock: XETR: ZEG
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.